Skip to content

?Duration of brain electrical stimulation and magnitude of motor recovery among paretic stroke patients

Short term versus long term use of Transcranial Direct Current Stimulation (tDCS) in rehabilitation of upper limb paresis among stroke patients, A randomized double blind clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014052617867N1
Enrollment
12
Registered
2014-07-01
Start date
2014-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke patients. stroke

Interventions

Intervention 1: Stimulation will be delivered by use of a battery-driven constant current stimulator. Stimulation parameters: stimulation will be increased from zero to two miliampere within thirty s
Rehabilitation
Stimulation will be delivered by use of a battery-driven constant current stimulator. Stimulation parameters: stimulation will be increased from zero to two miliampere within thirty seconds and will
Stimulation will be delivered by use of a battery-driven constant current stimulator. Stimulation parameters: stimulation will be increased from zero to two miliampere within thirty seconds and will

Sponsors

Tehran University of Medical Sciences
Lead Sponsor
Isfahan Cardiovascular Research Institute
Collaborator

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: Stroke patients whose symptoms start within the last six weeks; stroke patients who suffer from upper extremity paresis due to stroke. Exclusion criteria will be: If summation of shoulder abduction and finger extension forces in the affected side is greater than eight (in Medical Research Council Scale); if stroke patients have decreased level of consciousness; if intracerebral hemorrhage (ICH) events occur in the last four days before recruitment; if ischemic stroke events occur in the last two days before recruitment; if patients have metal foreign bodies in their heads; if patients do not sign the consent forms; if they can not come regularly for six months after their first visit; if patients do not have reliable relatives that can be educated to use tDCS in their homes; if patients have dementia before current stroke; if patients develop aphasia or dementia after stroke.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Score in Action Research Arm Test. Timepoint: Before intervention, week 2, month 1, month 2, month 4, month 6. Method of measurement: Action Research Arm Test.;Score in upper extremity part of Fugl-Meyer test. Timepoint: Before intervention, week 2, month 1, month 2, month 4, month 6. Method of measurement: Fugl-Meyer test.

Secondary

MeasureTime frame
Adverse events. Timepoint: Week 2, month 1, month 2, month 4, month 6. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Reza Zandi

Tehran University of Medical Sciences

dralizandi@yahoo.com+98 913 000 4063

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026